Xultophy 100/3.6 Launch Lies

Discussion in 'Novo Nordisk' started by anonymous, May 15, 2017 at 9:38 PM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Does anyone remember when we were in Vegas and they said the Xultrophy launch would be lucrative like Saxenda?

    Am I missing something?

    Xultophy 100/3.6 is worth 6 basal scripts.
    However, if you take from a Tresiba script which is worth 3 basal and a Victoza that is worth 1 that takes it to 4 scripts your losing. Im no genies but that's only a 2 script difference.
    Oh but wait there is more. Victoza is more lucrative at $20 per script over goal and a basal script is only worth $6 per script. So really to me, Xultophy 100/3.6 is only worth 1 script.

    At least as a monetary value.
    Am I looking at this the wrong way?
     

  2. anonymous

    anonymous Guest

    Lucrative for the company. Not the rep. That's what you're missing.